Amylyx nears trial results for rare endocrine drug

Amylyx Pharmaceuticals is set to announce results from its pivotal study for a new treatment targeting a rare endocrine disorder. The drug, if successful, could offer new hope for patients with specific hormonal imbalances and provide a significant boost for the company.